IP Library Granted Patent US 7,629,137
Granted Patent B2
US 7,629,137 · App. 11/416,998 · Granted Dec 8, 2009

Methods and apparatus for detecting bacteria using an acoustic device

Assignee: BioScale, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,629,137
App. No.
11/416,998
Granted
Dec 8, 2009
Kind
B2
Abstract

Methods for detecting bacteria are provided. A plurality of particles, each of which is coated with a capture agent having an affinity for the bacteria, is combined with the sample to form a plurality of analyte-particle complexes. The system also includes a transport arrangement for transporting the sample to the sensor surface, and optionally a magnetic field inducing structure constructed and arranged to establish a magnetic field at and adjacent to the sensor surface. The resonant sensor produces a signal corresponding to an amount of analyte-particle complexes that are bound to the sensor surface.

Claims (42)

1. A method for detecting bacteria in a sample, the method comprising the steps of:

a) introducing a fluid comprising a sample and a plurality of magnetic particles coated with a first capture agent capable of binding the bacteria into a fluid chamber, wherein at least one surface of the fluid chamber comprises a flexural plate wave device having a second capture agent capable of binding the bacteria, wherein the flexural plate wave device comprises a membrane that is capable of vibrating, and wherein the second capture agent is bound to the membrane;

b) applying a retractable source of magnetic flux positioned external to the fluid chamber close to the membrane to create a significant magnetic field gradient at a surface of the membrane to attract magnetic particles in the fluid toward the membrane;

c) monitoring a first signal output by said flexural plate wave device, wherein the first signal output is monitored in the presence of a magnetic flux;

d) after removing the retractable source of magnetic flux, flowing a solution through the fluid chamber to remove magnetic particles not bound to the membrane;

e) monitoring a second signal output by said flexural plate wave device, wherein the second signal output is monitored in the absence of the magnetic flux; and

f) comparing the first and the second signal output to a control signal, thereby detecting bacteria in the sample.

2. The method of claim 1 , wherein prior to being introduced into the fluid chamber, said plurality of particles has been exposed to the sample.

3. The method of claim 1 , wherein the sample has been introduced into the fluid chamber prior to introducing the plurality of particles.

4. The method of claim 1 , wherein the sample is selected from the group consisting of sputum, nasal swab, blood, plasma, serum, cerebrospinal fluid, urine and fecal matter.

5. The method of claim 1 , wherein the sample is selected from poultry wash and meat.

6. The method of claim 1 , wherein the bacteria is selected from the group consisting of pathogenic E. coli., Neisseria gonorrhoeae, Borrelia burgdorferi, Vibrio cholerae, Corynebacterium diphtheriae, Salmonella typhimurium, Salmonella enterica , and Helicobacter pylori.

7. The method of claim 1 , wherein the control signal is obtained in the absence of sample.

8. The method of claim 1 , wherein the control signal is a standard curve.

9. The method of claim 1 , wherein said second capture agent capable of binding the bacteria is indirectly bound to said surface.

10. The method of claim 9 , wherein said surface is coated with a first member of a binding pair, and said second capture agent is bound to a second member of the binding pair.

11. The method of claim 10 , wherein the first member of the binding pair is biotin.

12. The method of claim 1 , wherein the first or second capture agent is an antibody.

13. The method of claim 1 , wherein the first capture agent and the second capture agent are the same capture agent.

14. The method of claim 1 , wherein the sample comprises meat or poultry wash and wherein the method further comprises assessing food safety by detecting bacteria in a sample.

15. A method for assessing food safety by detecting bacteria in a sample, the method comprising the steps of:

a) introducing a fluid comprising a sample and a plurality of magnetic particles coated with a first capture agent capable of binding the bacteria into a fluid chamber, wherein at least one surface of the fluid chamber comprises a flexural plate wave device having a second capture agent capable of binding the bacteria, wherein the flexural plate wave device comprises a membrane that is capable of vibrating, and wherein the second capture agent is bound to the membrane;

b) applying a retractable source of magnetic flux positioned external to the fluid chamber close to the membrane to create a significant magnetic field gradient at a surface of the membrane to attract magnetic particles in the fluid toward the membrane;

c) monitoring a first signal output by said flexural plate wave device, wherein the first signal output is monitored in the presence of a magnetic flux;

d) after removing the retractable source of magnetic flux, flowing a solution through the fluid chamber to remove magnetic particles not bound to the membrane;

e) monitoring a second signal output by said flexural plate wave device, wherein the second signal output is monitored in the absence of the magnetic flux; and

f) comparing the first and the second signal output to a control signal, thereby detecting bacteria in the sample.

16. The method of claim 15 , wherein prior to being introduced into the fluid chamber, said plurality of particles has been exposed to the sample.

17. The method of claim 15 , wherein the sample has been introduced into the fluid chamber prior to introducing the plurality of particles.

18. The method of claim 15 , wherein the sample is selected from the group consisting of blood, plasma, serum, cerebrospinal fluid, urine and fecal matter.

19. The method of claim 15 , wherein the sample is selected from poultry wash and meat.

20. The method of claim 15 , wherein the bacteria is selected from the group consisting of pathogenic E. coli, Neisseria gonorrhoeae, Borrelia burgdorferi, Vibrio cholerae, Corynebacterium diphtheriae, Salmonella typhimurium, Salmonella enterica , and Helicobacter pylori.

21. The method of claim 15 , wherein the control signal is obtained in the absence of sample.

22. The method of claim 15 , wherein the control signal is a standard curve.

23. The method of claim 15 , wherein said second capture agent capable of binding the bacteria is indirectly bound to said surface.

24. The method of claim 23 , wherein said surface is coated with a first member of a binding pair, and said second capture agent is bound to a second member of the binding pair.

25. The method of claim 24 , wherein the first member of the binding pair is biotin.

26. The method of claim 15 , wherein the first or second capture agent is an antibody.

27. The method of claim 11 , wherein the second member of the binding pair is a derivative of avidin.

28. The method of claim 24 , wherein the second member of the binding pair is a derivative of avidin.

29. The method of claim 1 , wherein a fluid flows across the membrane during one or more of steps a), b), c) and e).

30. The method of claim 15 , wherein a fluid flows across the membrane during one or more of steps a), b), c) and e).

Assignments (2)
CHANGE OF NAME Recorded Jun 17, 2016
From: BIOSCALE, INC.
To: PROTERIXBIO, INC.
Reel/Frame 039069/0923 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2006
From: SAUER-BUDGE, ALEXIS F.; FITCH, ERIC; MASTERS, BRETT P.; MILLER, MICHAEL; LUNDSTROM, MARK
To: BIOSCALE, INC.
Reel/Frame 018270/0335 →
Continuity (4)
Continuation In Part 1118348400 · Jul 18, 2005
Provisional Application 6069059200 · Jun 15, 2005
Provisional Application 6067675900 · May 2, 2005
Related Publication 20070037231A1 · Feb 15, 2007